After ART insurance coverage in Japan, overall CE diagnostic methods and CD138 adoption remained largely unchanged. However, facilities tended to adopt higher CD138 cutoff values and treatment selections shifted. Establishing unified diagnostic criteria and treatment protocols is warranted to support standardized CE care for future health insurance coverage.
Jwa et al. (Wed,) studied this question.